Examination of Biomarker Expressions in Sepsis-related DIC Patients

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2018 Sep 27

PMID 30254480

Citations 7

Authors

Michiomi Shimizu

Akiko Konishi

Shosaku Nomura

Affiliations

Soon will be listed here.

Abstract

Background: Disseminated avascular coagulation (DIC) is the main cause of death among patients with sepsis. In particular, low platelet count is predictive of poor outcome. However, the significance of platelet activation in patients with sepsis-related DIC is poorly understood. To determine the characteristics of platelet-related abnormality in patients with sepsis-related DIC, we assessed the expression levels of several biomarkers.

Methods: Plasma levels of biomarkers, including cytokines, chemokines, soluble selectins, platelet-derived microparticles (PDMPs), soluble vascular adhesion molecule 1, and high mobility group box protein 1 were measured by enzyme-linked immunosorbent assay at baseline and after 4, 7, 14, and 21 days of DIC treatment.

Results: Differences in platelet activation and in the elevation of activated platelet-related PDMPs and of soluble P-selectin were seen between patients suffering from sepsis and hematologic malignancy with DIC. In addition, the elevation of interleukin (IL)-6 and thrombopoietin (TPO) was significant in sepsis patients with DIC. Furthermore, IL-6 and TPO promoted platelet activation in vitro.

Conclusion: Assessment of PDMPs, sP-selectin, IL-6, and TPO may be beneficial in the primary prevention of multi-organ failure in sepsis patients with DIC.

Citing Articles

Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.

Kashiwagi H, Kuwana M, Murata M, Shimada N, Takafuta T, Yamanouchi J Int J Hematol. 2023; 119(1):1-13.

PMID: 37957517 PMC: 10770234. DOI: 10.1007/s12185-023-03672-1.

The Role of Platelet-Derived Extracellular Vesicles in Immune-Mediated Thrombosis.

Eustes A, Dayal S Int J Mol Sci. 2022; 23(14).

PMID: 35887184 PMC: 9320310. DOI: 10.3390/ijms23147837.

Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.

Lopes-Pires M, Frade-Guanaes J, Quinlan G Antioxidants (Basel). 2022; 11(1).

PMID: 35052592 PMC: 8773140. DOI: 10.3390/antiox11010088.

Detection of Sepsis in Platelets Using MicroRNAs and Membrane Antigens.

Vieira Correa P, Carneiro D, da Silva Valente L, Diogo F, Lamarao L, Maues J Genes (Basel). 2021; 12(12).

PMID: 34946826 PMC: 8701354. DOI: 10.3390/genes12121877.

Humanized Mice as a Tool to Study Sepsis-More Than Meets the Eye.

Laudanski K Int J Mol Sci. 2021; 22(5).

PMID: 33673691 PMC: 7957591. DOI: 10.3390/ijms22052403.

References

Zakynthinos S, Papanikolaou S, Theodoridis T, Zakynthinos E, Christopoulou-Kokkinou V, Katsaris G . Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med. 2004; 32(4):1004-10. DOI: 10.1097/01.ccm.0000121433.61546.a0. View

Montrucchio G, Brizzi M, Calosso G, Marengo S, Pegoraro L, Camussi G . Effects of recombinant human megakaryocyte growth and development factor on platelet activation. Blood. 1996; 87(7):2762-8. View

Li H, Meng X, Liang X, Gao Y, Cai S . Administration of microparticles from blood of the lipopolysaccharide-treated rats serves to induce pathologic changes of acute respiratory distress syndrome. Exp Biol Med (Maywood). 2015; 240(12):1735-41. PMC: 4935343. DOI: 10.1177/1535370215591830. View

Woth G, Tokes-Fuzesi M, Magyarlaki T, Kovacs G, Vermes I, Muhl D . Activated platelet-derived microparticle numbers are elevated in patients with severe fungal (Candida albicans) sepsis. Ann Clin Biochem. 2012; 49(Pt 6):554-60. DOI: 10.1258/acb.2012.011215. View

Lupia E, Bosco O, Mariano F, Dondi A, Goffi A, Spatola T . Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation. J Thromb Haemost. 2009; 7(6):1000-8. DOI: 10.1111/j.1538-7836.2009.03348.x. View

Taylor Jr F, Toh C, Hoots W, Wada H, Levi M . Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2002; 86(5):1327-30. View

Yadav H, Kor D . Platelets in the pathogenesis of acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2015; 309(9):L915-23. PMC: 4628982. DOI: 10.1152/ajplung.00266.2015. View

Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H . High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 1996; 88(9):3456-64. View

Nomura S . Microparticle and Atherothrombotic Diseases. J Atheroscler Thromb. 2015; 23(1):1-9. DOI: 10.5551/jat.32326. View

10.

Mortaza S, Martinez M, Baron-Menguy C, Burban M, de la Bourdonnaye M, Fizanne L . Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats. Crit Care Med. 2009; 37(6):2045-50. DOI: 10.1097/CCM.0b013e3181a00629. View

11.

Valerio-Rojas J, Jaffer I, Kor D, Gajic O, Cartin-Ceba R . Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study. Crit Care Res Pract. 2013; 2013:782573. PMC: 3590611. DOI: 10.1155/2013/782573. View

12.

Ince C, Mayeux P, Nguyen T, Gomez H, Kellum J, Ospina-Tascon G . THE ENDOTHELIUM IN SEPSIS. Shock. 2016; 45(3):259-70. PMC: 5281063. DOI: 10.1097/SHK.0000000000000473. View

13.

Yaguchi A, Lobo F, Vincent J, Pradier O . Platelet function in sepsis. J Thromb Haemost. 2004; 2(12):2096-102. DOI: 10.1111/j.1538-7836.2004.01009.x. View

14.

Nomura S, Ozaki Y, Ikeda Y . Function and role of microparticles in various clinical settings. Thromb Res. 2008; 123(1):8-23. DOI: 10.1016/j.thromres.2008.06.006. View

15.

Tokes-Fuzesi M, Woth G, Ernyey B, Vermes I, Muhl D, Bogar L . Microparticles and acute renal dysfunction in septic patients. J Crit Care. 2012; 28(2):141-7. DOI: 10.1016/j.jcrc.2012.05.006. View

16.

Yeo E, Sheppard J, Feuerstein I . Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model). Blood. 1994; 83(9):2498-507. View

17.

Walborn A, Hoppensteadt D, Syed D, Mosier M, Fareed J . Biomarker Profile of Sepsis-Associated Coagulopathy Using Biochip Assay for Inflammatory Cytokines. Clin Appl Thromb Hemost. 2017; 24(4):625-632. PMC: 6714703. DOI: 10.1177/1076029617709084. View

18.

Ikezoe T . Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin. Int J Hematol. 2013; 100(1):27-37. DOI: 10.1007/s12185-013-1463-0. View

19.

Nomura S, Inami N, Kanazawa S, Iwasaka T, Fukuhara S . Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF. Stem Cells. 2004; 22(5):696-703. DOI: 10.1634/stemcells.22-5-696. View

20.

Greco E, Lupia E, Bosco O, Vizio B, Montrucchio G . Platelets and Multi-Organ Failure in Sepsis. Int J Mol Sci. 2017; 18(10). PMC: 5666881. DOI: 10.3390/ijms18102200. View